A new concept for risk assessment of the hazards of non-genotoxic chemicals--electronmicroscopic studies of the cell surface. Evidence for the action of lipophilic chemicals on the Ca2+ signaling system.
Recently, we presented evidence for the localization of components of the cellular Ca2+ signaling pathway in microvilli. On stimulation of this pathway, microvilli undergo characteristic morphological changes which can be detected by scanning electron microscopy (SEM) of the cell surface. Here we show that both receptor-mediated (vasopressin) and unspecific stimulation of the Ca2+ signaling system by the lipophilic tumor promoters thapsigargin (TG) and phorbolmyristateacetate (PMA) are accompanied by the same type of morphological changes of the cell surface. Since stimulated cell proliferation accelerates tumor development and sustained elevation of the intracellular Ca2+ concentrations is a precondition for stimulated cell proliferation, activated Ca2+ signaling is one possible mechanism of non-genomic tumor promotion. Using isolated rat hepatocytes we show that all tested lipophilic chemicals with known tumor promoter action, caused characteristic microvillar shape changes. On the other hand, lipophilic solvents that were used as differentiating agents in cell cultures such as dimethylsulfoxide (DMSO) and dimethylformamide also, failed to change the microvillar shapes. Instead DMSO stabilized the original appearance of microvilli. The used technique provides a convenient method for the evaluation of non-genomic carcinogenicity of chemicals prior to their industrial application.
Gartzke
J
J
Federal Institute for Occupational Safety and Health, Berlin, Germany.
Lange
K
K
Brandt
U
U
Bergmann
J
J
D000473:Alkanes / Q000633:toxicity; D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002246:Carbon Disulfide / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002800:Cholinesterase Inhibitors / Q000633:toxicity; D004121:Dimethyl Sulfoxide / Q000633:toxicity; D004126:Dimethylformamide / Q000633:toxicity; D000431:Ethanol / Q000633:toxicity; D006588:Hexanones / Q000633:toxicity; D008099:Liver / Q000166:cytology / Q000187:drug effects* / Q000648:ultrastructure; D008855:Microscopy, Electron, Scanning; D008871:Microvilli / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D051381:Rats; D017483:Receptors, Vasopressin / Q000187:drug effects; D018570:Risk Assessment; D015398:Signal Transduction / Q000187:drug effects*; D012997:Solvents / Q000633:toxicity*; D020058:Styrene; D013343:Styrenes / Q000633:toxicity; D013755:Tetradecanoylphorbol Acetate / Q000633:toxicity; D019284:Thapsigargin / Q000633:toxicity; D014050:Toluene / Q000633:toxicity
D000473:Alkanes; D002273:Carcinogens; D002800:Cholinesterase Inhibitors; D006588:Hexanones; D017483:Receptors, Vasopressin; D012997:Solvents; D013343:Styrenes; D014050:Toluene; D000431:Ethanol; D020058:Styrene; D019284:Thapsigargin; D004126:Dimethylformamide; C011269:2,5-hexanedione; C022884:undecane; D013755:Tetradecanoylphorbol Acetate; D002246:Carbon Disulfide; D002118:Calcium; D004121:Dimethyl Sulfoxide